SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-175903
Filing Date
2024-07-08
Accepted
2024-07-08 06:59:00
Documents
21
Period of Report
2024-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d791725d8k.htm   iXBRL 8-K 50345
2 EX-2.1 d791725dex21.htm EX-2.1 484534
3 EX-10.1 d791725dex101.htm EX-10.1 68846
4 EX-10.2 d791725dex102.htm EX-10.2 63482
5 EX-10.3 d791725dex103.htm EX-10.3 65518
6 EX-99.1 d791725dex991.htm EX-99.1 19366
10 GRAPHIC g791725dsp9a.jpg GRAPHIC 3689
11 GRAPHIC g791725dsp9b.jpg GRAPHIC 5620
12 GRAPHIC g791725dsp9c.jpg GRAPHIC 7335
  Complete submission text file 0001193125-24-175903.txt   1093525

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA morf-20240707.xsd EX-101.SCH 2843
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE morf-20240707_lab.xml EX-101.LAB 17993
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE morf-20240707_pre.xml EX-101.PRE 11256
24 EXTRACTED XBRL INSTANCE DOCUMENT d791725d8k_htm.xml XML 3714
Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 (781) 996-0955
Morphic Holding, Inc. (Filer) CIK: 0001679363 (see all company filings)

IRS No.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38940 | Film No.: 241103332
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)